Approval · Notice of Compliance 1133 · 2000

LOVENOX: Notice of Compliance 1133

Issued December 19, 2000

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 1133
Date: December 19, 2000
Company: Aventis Pharma Inc.Laval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Anticoagulant/antithrombotic agent

Products in this notice

Brand	DIN	Status today
LOVENOX	02012472	Marketed
LOVENOX	02236564	Marketed
LOVENOX	02236883	Marketed

Medicinal ingredients

ENOXAPARIN SODIUM 30 MG per 0.3ML
ENOXAPARIN SODIUM 10 MG per 0.1ML
ENOXAPARIN SODIUM 40 MG per 0.4ML